UPDATE: Atossa Genetics Offers Regulatory, Commercial Update on ForeCYTE Aspirator, Device Ruled 'Not Substantially Equivalent'
September 23, 2014 at 16:03 PM EDT
Atossa Genetics Inc. (NASDAQ: ATOS) today announced that the U.S. Food and Drug Administration has issued a determination that the ...
